A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Clinical trial NCT05283720 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05283720
- Sponsor
- Genmab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2032-11-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.